GlaxoSmithKline Pharmaceuticals

BSE : 500660 | NSE : GLAXO

Industry : Pharma MNC | ISIN : INE159A01016 | FreeFloat : 50.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)1,773.91
Net Worth (NW)1,499.08
Intrinsic Worth (IW)3,272.99
Market Cap (MC)24,407.17
Economic Value Added-23.58
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)54.20%
IC Gross Margin (EBITDA/IC)36.30%
IC Net Margin (NPT/IC)13.81%
Knowledge Turnover (Sales/IC)1.81
Market to Intrinsic Value (MC/IW)7.46

As OfIntrinsic ValueMarket Price
31 Mar 2021Rs. 193.20Rs. 1,440.75
22 Jun 2021 - Rs. 1,510.75
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 1,531.64SellStrong Sell
KB > 50% : Yes50 DMA : Rs. 1,486.42
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-18
C
735.65
753.66
135.63
124.27
133.80
84.08
84.08
Sep-18
C
816.31
831.32
165.03
153.52
156.52
100.83
100.83
Dec-18
C
825.03
841.61
137.08
125.04
193.52
136.72
136.72
Mar-19
C
751.13
803.85
163.05
149.37
198.82
123.76
123.76
Jun-19
C
787.97
818.78
165.29
146.23
176.11
113.54
113.54
Sep-19
C
882.02
897.90
194.01
171.31
587.41
502.75
502.75
Dec-19
C
778.59
795.09
124.39
106.06
-634.32
-661.16
-661.16
Mar-20
C
775.80
791.62
200.65
178.06
176.55
138.07
138.60
Jun-20
C
648.59
706.51
171.99
150.22
149.14
110.83
107.80
Sep-20
C
879.32
888.36
149.77
127.81
126.93
76.47
76.47
Dec-20
C
857.20
871.22
230.06
212.35
211.41
156.51
156.51
Mar-21
C
813.75
843.35
81.49
63.64
63.01
14.33
12.40
* C - Consolidated, S - Standalone